Related Experiment Videos

A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease

M Woodward1, A Rumley, P Welsh

  • 1Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, UK.

Insights

Inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6) are linked to coronary heart disease (CHD) risk. D-dimer and IL-6 show potential for improving CHD risk prediction beyond traditional factors.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Hemostasis Research

Background:

  • Established links exist between hemostatic variables and coronary heart disease (CHD) risk.
  • Some hemostatic variables may function as acute-phase reactants, influenced by inflammation.

Purpose of the Study:

  • To investigate the association between hemostatic variables and inflammatory markers (CRP, IL-6).
  • To assess the impact of adjusting for inflammatory markers and conventional risk factors on the association between hemostatic variables and CHD risk.

Main Methods:

  • Nested case-control study within the Fletcher Challenge cohort (10,529 participants).
  • 247 CHD cases and 473 controls matched for age and sex.
  • Analysis of plasma levels of hemostatic variables, CRP, and IL-6, with multivariable adjustments.

Main Results:

  • Most hemostatic variables correlated with CRP and IL-6, excluding VWF and Lp(a).
  • Fibrinogen, VWF, t-PA, D-dimer, Lp(a), CRP, and IL-6 were associated with CHD risk.
  • After adjusting for conventional risk factors, CRP, D-dimer, and IL-6 remained significant predictors of CHD risk.

Conclusions:

  • Associations of fibrinogen, VWF, t-PA, and Lp(a) with CHD risk were attenuated by inflammatory markers and conventional risk factors.
  • D-dimer and IL-6 showed sustained significant associations with CHD risk, even after multivariable adjustments.
  • D-dimer and IL-6 may enhance the prediction of CHD risk independently of conventional factors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...